Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets Media Outreach|28/08/2024oleh RRINEWSS SINGAPORE – Media OutReach Newswire – 28 August 2024 – Zuellig Pharma, a leading
Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia Media Outreach|19/07/2024oleh RRINEWSS New agreement marks major milestone for Zuellig Pharma as it focuses on
Zuellig Pharma and Karo Healthcare strengthen partnership across key markets in Asia Media Outreach|18/03/2024oleh RRINEWSS SINGAPORE – Media OutReach Newswire – 18 March 2024 – Zuellig Pharma, a leading
Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV® vaccine for Japanese encephalitis across Asia Media Outreach|16/01/2024oleh RRINEWSS New commercialisation agreement builds on existing partnership with Zuellig Pharma SINGAPORE – Media
Media OutReach Zuellig Pharma awarded EcoVadis Platinum Medal for third consecutive year and rated leader in carbon management Media Outreach|13/09/2023oleh RRINEWSS SINGAPORE – Media OutReach – 13 September 2023 – Zuellig Pharma, a leading healthcare
Media OutReach Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines Media Outreach|01/08/2023oleh RRINEWSS Pitch Notes: Zuellig Pharma today announced that it has entered into an
Media OutReach Interpharma Investments Limited Appoints Alfonso “Chito” Zulueta As Non-Executive Chairman Media Outreach|05/05/202308/05/2023oleh RRINEWSS Pitch Notes: Interpharma Investments Limited, holding company of leading healthcare services provider
